Molecular Signatures and Their Clinical Utility in Pancreatic Neuroendocrine Tumors.

As it is central to multiple tumorigenic pathways, downregulation of mTOR pathway inhibitors such as PTEN and TSC2 was a highly significant finding (~85%) in a gene expression profiling of PNETs, even in the absence of a pathway-specific mutation.

also in 132,142 other papers